Obesity may not affect unplanned health care utilization, safety of therapy in IBD

SAN DIEGO — Obesity was not linked to hospitalization, surgery or serious infection among a subset of biologic-treated patients with inflammatory bowel disease, according to research presented at Digestive Disease Week 2022.“Obesity is a risk factor for suboptimal biological response, and population pharmacokinetic studies have consistently shown that increased body mass is associated with increased clearance and decreased stroke levels,” Phillip T. Gu, MD, of Cedars-Sinai Medical Center in Los Angeles, said. “There’s very limited data on how obesity affectsRead More